Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
Tumor-specific metabolic rewiring, acquired to confer a proliferative and survival advantage over nontransformed cells, represents a renewed focus in cancer therapy development. Hepatocellular carcinoma (HCC), a malignancy that has hitherto been resistant to compounds targeting oncogenic signaling p...
Main Authors: | Chong, Yong Chun, Toh, Tan Boon, Chan, Zhiling, Lin, Quy Xiao Xuan, Thng, Dexter Kai Hao, Hooi, Lissa, Ding, Zhaobing, Shuen, Timothy, Toh, Han Chong, Dan, Yock Young, Bonney, Glenn Kunnath, Zhou, Lei, Chow, Pierce, Wang, Yulan, Benoukraf, Touati, Chow, Edward Kai-Hua, Han, Weiping |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/144809 |
Similar Items
-
Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023) -
Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
by: Obaid Al-Qubaisi, Mothanna Sadiq
Published: (2009) -
Unravelling the role of obesity and lipids during tumor progression
by: Zhao, Junzhe, et al.
Published: (2023) -
Prognosis prediction of hepatocellular carcinoma based on magnetic resonance imaging features
by: Low, Hsien Min, et al.
Published: (2023) -
Outcomes of patients with post-hepatectomy hypophosphatemia: a narrative review
by: Chan, Kai Siang, et al.
Published: (2022)